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L E T T E R  T O  T H E  E D I T O R
Pollen induces reactivation of latent herpesvirus and 
differentially affects infected and uninfected murine 
macrophages
To the Editor,
Aeroallergens including plant pollen are continuously inhaled and 
deposited in the respiratory tract and, together with their soluble 
components, actively interact with a variety of cells in the airways.1 
Besides epithelial cells, B cells,2 dendritic cells,3 and macrophages4 
play a prominent role in these interactions. Apart from causing al-
lergic diseases, pollen exposure might also affect host-pathogen 
interactions. Both, pollen and pathogens including viruses, may be 
encountered in the respiratory tract at the same time and by the same 
cells. For example, it has been shown that pollen exposure weakens 
the innate defense against respiratory viruses.5 Other viruses that 
are omnipresent in humans are herpesviruses, due to their capability 
to persist lifelong in the host.6 Therefore, a co-occurrence of pollen 
exposure and herpesvirus infection is likely. We have recently shown 
that cells persistently infected with gammaherpesviruses responded 
to environmental nanoparticle exposure by reactivation of latent 
virus.7 Therefore, we hypothesized that additional airborne factors 
like plant pollen might reactivate latent herpesvirus too.
To answer this question, persistently murine gammaherpesvirus 
68 (MHV-68)-infected macrophages (ANA-1-MHV-68)7 were incu-
bated with pollen grains or aqueous pollen extracts (APEs), and lytic 
virus was determined in the supernatant. As shown in Figure 1, both 
pollen grains (Figure 1A) and APEs (Figure 1B) resulted in an increase 
of lytic virus in the supernatant, when compared to the control, with 
significant increases after stimulation with Amb-pollen grains and all 
tested APEs.
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Abbreviations: Aln-APE, aqueous extract of alder (Alnus glomerata) pollen; Amb-APE, aqueous extract of ragweed (Ambrosia artemisiifolia) pollen; ANA-I, murine macrophage cell line; 
APE, aqueous pollen extract; Arg 1, arginase 1 (=M2-specific marker); Bet-APE, aqueous extract of birch (Betula pendula) pollen; CCL, CC-motif family chemokine; Cor-APE, aqueous 
extract of hazel (Corylus avellana) pollen; CXCL, CXCL-motif family chemokine; IFN, interferon; IL, interleukin; iNOS, induced nitric oxide synthase (=M1-specific marker); LPS, 
lipopolysaccharide; M1, pro-inflammatory macrophage; M2, alternatively activated macrophage; MHV-68, murine gammaherpesvirus-68; MΦ, macrophage; PCA, principal component 
analysis; Phl-APE, aqueous extract of timothy grass (Phleum pratense) pollen; t-SNE, t-distributed stochastic neighbor embedding.
F I G U R E  1   Exposure to pollen grains (A) or APE (B) induces reactivation of latent herpesvirus. ANA-1-MHV-68 were incubated with the 
indicated stimuli, and lytic virus was determined in supernatants by plaque assay after 72 h. Untreated cells were set as “1,” and the values 
for cells after stimulation were calculated relative to the control. Each black dot represents the value from an individual experiment. The 
columns reflect the means ± SD from the number of independent experiments indicated at the bottom of each column. APE, aqueous pollen 
extract; Aln: alder (Alnus); Bet: birch (Betula); Cor: hazel (Corylus); Phl: grasses (Phleum); Amb: ragweed (Ambrosia) [Color figure can be viewed 
at wileyonlinelibrary.com]
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Additionally, we compared the response of ANA-1-MHV-68 to that 
of the respective uninfected parental macrophages (ANA-1).7 First, 
we analyzed metabolic activity, apoptosis, and viability (Figure S1A-
D). Overall, we did neither observe significant changes in response 
to stimulation nor between infected and uninfected macrophages. 
To evaluate whether stimulation with pollen grains or APEs leads to 
polarization into “M1” or “M2” macrophages, the mRNA expression 
of iNOS (“M1”) and Arg1 (“M2”) was determined. ANA-1-MHV-68 dis-
played an overall higher expression of iNOS (Figure 2A) and lower ex-
pression of Arg1 (Figure 2B). Within each cell line, exposure to pollen 
grains or APE did not significantly change the mRNA expression of the 
marker genes, with a few exceptions: Aln-pollen grains significantly 
upregulated iNOS in ANA-1-MHV-68 (Figure 2A), while Cor-APE 
significantly upregulated Arg1 in ANA-1 (Figure 2B). LPS increased 
iNOS in ANA-1 (Figure 2A). IL-4 increased Arg1 in both ANA-1 and 
ANA-1-MHV-68 (Figure 2B). Both Amb-pollen grains and LPS signifi-
cantly downregulated Arg1 in ANA-I (Figure 2B). In addition, we de-
termined the surface expression of CD86 (“M1”) and CD206 (“M2”) by 
flow cytometry, and the cytokine and chemokine release by multiplex 
assays of cell culture supernatants. CD86 was significantly higher ex-
pressed on ANA-1 (Figure 2C). CD206 was expressed less on both cell 
lines (Figure 2D). In both cell lines, stimulation with pollen grains or 
APEs did not significantly change the expression of CD86 or CD206, 
with the exception that Aln-pollen grains upregulated, and IL-4 down-
regulated, CD86 expression in ANA-1 (Figure 2C). Regarding cyto-
kines and chemokines, uninfected cells secreted higher levels of both 
cytokines (Figure 2E) and chemokines (Figure 2F) than infected cells. 
LPS stimulation of uninfected cells induced a “M1”-specific profile, 
while stimulation with IL-4 led to a “M2”-specific profile (Figure S2A). 
Uninfected cells stimulated with APEs resembled a phenotype close 
F I G U R E  2   Exposure to pollen grains or aqueous pollen extract (APE) influences marker expression and cytokine and chemokine 
production. Cells were incubated with the indicated stimuli for 72 h, and the mRNA expression of iNOS (A) and Arg1 (B) was determined 
by RT-PCR. Data are expressed as relative gene expression compared to β-actin. The columns reflect the means ± SD from the number of 
independent experiments indicated at the bottom of each column. The surface expression of CD86 (C) and CD206 (D) was determined by 
flow cytometry. Shown are mean fluorescence intensities (MFI) ± SD from three independent experiments. The asterisks on top of the error 
bars indicate statistical significance between the indicated condition and the medium control and the asterisks above the brackets between 
the two cell lines. Cytokine (E) and chemokine production (F) was analyzed by multiplex assays. Data shown are means derived from 2 to 4 
independent samples per condition [Color figure can be viewed at wileyonlinelibrary.com]
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to “M2,” whereas stimulation with pollen grains induced a distinct, 
“M1-like” profile. Stimulation of infected cells with LPS resulted in a 
profile characterized by high levels of IL-6 and TNF-α, while IL-4 stim-
ulation mainly resulted in a marked upregulation of CCL-24. Bet-pollen 
induced a mixed phenotype, and Aln-pollen induced a more “M1-like” 
phenotype (Figure S2B). To further visualize phenotypic similarities, 
we applied t-distributed stochastic neighbor embedding (t-SNE). In 
uninfected macrophages (Figure S2C), “M1” (LPS)- and “M2” (IL-4)-
polarized cells appeared clearly separated. Unstimulated and cells 
stimulated with APEs appeared more similar to “M2,” whereas cells 
stimulated with pollen appeared more similar to “M1.” The phenotypic 
segregation of “M1” and “M2” was even more pronounced in infected 
macrophages (Figure S2D). To identify the factors that contribute most 
to these differences, we performed factorial analysis of mixed data. 
For uninfected macrophages, dimensions 1 and 8 explained ≈35% of 
the overall variance (Figure S3A). The main contributing factor within 
dimension 1 was “treatment” (Figure S3B). For infected macrophages, 
dimensions 2 and 10 accounted for ≈16% of the overall variance 
(Figure S3C). Within dimension 2, the main contributing factor was 
again “treatment” (Figure S3D). Finally, to investigate whether stim-
ulation with pollen grains or APEs influences macrophage functions, 
we analyzed cAMP production and phagocytic capacity. In ANA-1-
MHV-68, baseline cAMP production was higher than in ANA-1, and 
there was a tendency toward decreased production after stimulation 
with IL-4 and pollen grains (Figure S4A). In ANA-1, stimulation with 
pollen grains decreased cAMP production to levels below detection, 
while LPS and IL-4 increased cAMP production. In both cell lines, APE 
did not change cAMP production. Treatment with pollen grains and 
APEs (except Aln-APE) decreased the phagocytic capacity of ANA-1-
MHV-68 (Figure S4B). However, a different response was observed in 
ANA-1. Here, APEs (again except Aln-APE) increased the phagocytic 
capacity, whereas it was not changed by stimulation with pollen grains 
(Figure S4B).
In conclusion, we show that pollen grains and APEs can induce 
reactivation of a latent gammaherpesvirus. This is in line with our re-
cent findings7 and identifies pollen as a hitherto unrecognized “novel” 
trigger of herpesvirus reactivation.8 Constantly recurring reactivation 
of herpesviruses by pollen grains and their associated compounds 
may result in chronic inflammatory processes that may lead to immu-
nopathology and disease. Notably, seasonal variation in reactivation 
and shedding of Epstein-Barr virus (EBV) in healthy adults has been 
described earlier, with an increase of EBV shedding in saliva during 
spring and autumn months.9 The authors hypothesized that one pos-
sible explanation might be that these months represent the peak al-
lergy seasons in the area where the study group was recruited. By 
causing an influx of infected immune cells, the increased presence of 
allergens might contribute to the increased shedding.9 Our data pro-
vide now the first experimental evidence for this hypothesis.
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Comparison of nasal allergen challenges with dissolved 
Timothy grass lower-case pollen tablets and aqueous extract
To the Editor,
We and others have used nasal allergen challenge (NAC) to in-
vestigate the clinical and immunological effects of allergen ex-
posure1-3 and the efficacy of immunotherapy.4 The procedure is 
safe and well tolerated.5 For NAC to be a valid tool, it is essential 
that the allergen extracts used are standardized. The availability 
of these extracts is limited in some areas. We have previously 
used an aqueous extract of Timothy Grass (Phleum pratense) pol-
len, Aquagen® (ALK-Abello), supplied as a dry powder, to be re-
constituted prior to use by dissolving in an albumin-based diluent, 
to 100 000 SQ-U/mL. Aqueous extract of Timothy Grass (Phleum 
pratense) pollen production has been discontinued, but the iden-
tical allergen is available as Timothy Grass lyophilisate tablets, 
Grazax® (ALK-Abello), 75 000 SQ-T, an approved, widely available 
and licensed product for treatment of severe seasonal allergic 
rhinitis. Timothy Grass lyophilisate tablets consists of purified, 
freeze-dried Timothy Grass pollen extract, plus three excipients, 
(fish) gelatine, mannitol and sodium hydroxide. We anticipated 
that the clinical effect when dissolved and used for NAC would 
be equivalent to the use of aqueous extract of Timothy Grass 
(Phleum pratense) pollen for a given allergen concentration. We 
therefore conducted a randomized-order, cross-over trial of NAC 
with the two allergen extracts.
Grass pollen allergic adults (18-65 years) and nonatopic con-
trols were recruited from the Allergy Clinic at Royal Brompton 
Hospital, London. For inclusion/exclusion criteria, see Appendix 
S1. Following screening, participants underwent two NACs, at 
least 4 weeks apart, between September 2019 and January 2020. 
Participants were randomized to have either NAC using aqueous 
extract first, dissolved tablet second, or vice versa. Nonatopics un-
derwent a single NAC with the dissolved tablet. Participants gave 
written, informed consent; the study was approved by regional 
ethics committee (ref.19/LO/1346) and registered with clinical-
trials.gov (NCT04078009). NACs were performed with aqueous 
extract/dissolved tablets diluted in 0.9% normal saline to 16 667 
SQ-U/mL or 16 667 SQ-T/mL (equivalent to 5000 BU/mL or ap-
proximately 1 mcg major allergen (Phl p 5)/mL, see Appendix S1 for 
further details). Total nasal symptom scores (TNSS, 0-12) and peak 
nasal inspiratory flow (PNIF) were recorded before NAC and at 5, 
15, 30 and 60 minutes. Peak expiratory flow (PEF) was recorded 
before and at 60 minutes. The primary endpoint was the area 
under the curve for TNSS 0-60 minutes (TNSS-AUC). The primary 
comparison was between NAC with aqueous extract and NAC with 
dissolved tablet. Secondary comparisons were between the first 
NAC and second NAC visit, and by first and second visit according 
to challenge extract.
Twenty-two volunteers were screened, of which 20 were in-
cluded (Table S1). All 20 participants completed both challenges 
except one who did not undergo visit 2 due to an upper respira-
tory tract infection. Ten nonatopic individuals underwent dissolved 
tablet NAC only. Mean TNSSs were similar during NACs with each 
extract at baseline, 5, 15, 30 and 60 minutes (Figure 1A). Mean 
TNSS AUC was no different between the two (P = .19, paired t 
test; Figure 1B). Mean change from baseline PNIFs was also similar 
at 5, 15, 30 and 60 minutes (Figure 1C), and AUC was not differ-
ent (P = .99; Figure 1D). Pearson's coefficient showed correlation 
between TNSS AUC following each challenge (r = .65, P = .002; 
Figure 1E). Bland-Altman plot of the difference between the TNSS 
AUC showed 18 of 19 (94.7%) paired results lying within ±1.96 
standard deviations of the mean (Figure 1F). NAC in nonatopic in-
dividuals had no effect on TNSS or PNIF (Figure 1A, C). Individual 
TNSS following nasal challenge with aqueous extract of Timothy 
Grass (Phleum pratense) pollen and Timothy Grass lyophilisate tab-
lets are depicted in Figure S3.
Whilst peak (5 minute) TNSS was equivalent at visits 1 and 2, 
mean scores at 15, 30 and 60 minutes were lower at visit 2 than 
visit 1, without reaching statistical significance (Figure 2A). Mean 
TNSS AUC was greater at visit 1 than visit 2 (P = .03; paired t test, 
Figure 2B). A similar trend was seen for ΔPNIF (Figure 2C, D). This 
effect appeared to be predominantly driven by participants who 
